# reload+after+2024-01-19 22:43:16.087659
address1§75/76 Wimpole Street
city§London
zip§W1G 9RT
country§United Kingdom
phone§44 20 8004 0270
website§https://www.akaritx.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-Barré syndrome, hematopoietic stem cell transplant-associated thrombotic microangiopathy, and bullous pemphigoid, as well as pre-clinical program developing long-acting PASylated-nomacopan for treatment of geographic atrophy secondary to dry age-related macular degeneration. The company is based in London, the United Kingdom.
fullTimeEmployees§15
companyOfficers§[{'maxAge': 1, 'name': 'Ms. Rachelle Suzanne Jacques', 'age': 52, 'title': 'President, CEO & Director', 'yearBorn': 1971, 'fiscalYear': 2022, 'totalPay': 1383198, 'exercisedValue': 0, 'unexercisedValue': 13590961}, {'maxAge': 1, 'name': 'Ms. Wendy F. DiCicco CPA', 'age': 56, 'title': 'Interim Chief Financial Officer', 'yearBorn': 1967, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Melissa  Bradford-Klug', 'age': 53, 'title': 'Chief Operating Officer', 'yearBorn': 1970, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Miles  Nunn', 'age': 54, 'title': 'Chief Scientific Officer', 'yearBorn': 1969, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. John F. Neylan III, M.D.', 'age': 70, 'title': 'Executive VP & Chief Medical Officer', 'yearBorn': 1953, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Beth-Anne  Lang', 'title': 'Senior Vice President of Regulatory Affairs', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Annie  Mack', 'title': 'Financial Controller', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§1.141
currency§USD
dateShortInterest§1702598400
forwardEps§-3.4
exchange§NCM
quoteType§EQUITY
shortName§Akari Therapeutics Plc
longName§Akari Therapeutics, Plc
firstTradeDateEpochUtc§1389018600
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§7ad3d9ad-13c2-3784-92d6-18475fbe0a3b
gmtOffSetMilliseconds§-18000000
targetHighPrice§80.0
targetLowPrice§80.0
targetMeanPrice§80.0
targetMedianPrice§80.0
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§1
quickRatio§1.373
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
